forgetting in the recall of sexual and drug injection partners.

NLM AIDSLINE Forgetting in the recall of sexual and drug injection partners. Brewer DD; Garrett SB; Kulasingam SL
December 30, 1998

Unique Identifier : AIDSLINE ICA12/98407102 BACKGROUND: Provider referral partner notification activities and social network studies of HIV transmission involve interviewing people to elicit their sexual and/or drag injection partners. Incomplete recall of partners in these contexts would significantly hamper efforts to understand and control the spread of HIV. Although many reasons exist why individuals might not name their partners in such interviews, memory factors are likely to figure prominently. METHODS: Subjects were 156 persons in

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 CANADA: Celibate Homosexual Men Now Allowed to Donate Blood in Canada AFRICA: UN: AIDS Deaths Down, Treatment Up in Africa MICHIGAN: STD Fee for Jackson County Walk-In Clinic Takes Effect June 3 NEW YORK: Catskill Hospital Warns That Insulin Pens May Have Been Reused DELAWARE: Cape Henlopen Theatre Academy to Host 'Magic to Do' May 25 GLOBAL: HIV Outcomes Could Improve by Integrating Treatment of Comorbid Mental Illness CANADA: Stop Paid Blood Donor Clinics in Toronto, Victims Say UNITED STATES: How Sexual Stigma Is Undermining HIV Treatment on American Indian Reservations HHS Office for Civil Rights launches campaign to increase awareness of HIPAA rights among HIV-positive Black men Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog UNITED STATES: How Sexual Stigma Is Undermining HIV Treatment on American Indian Reservations Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog Study Finds Vitamin C Can Kill Drug-Resistant TB Immune system cancer drugs tipped to be a $35 billion market TEXAS: Temple - Wellness and Sexual Health Classes Helping Kids to Abstain NEW JERSEY: Drug Company Donates Thousands to HIV/AIDS Orgs NORTH KOREA: North Korea Sees Surge of Drug-Resistant Tuberculosis Experimental Gilead drug effective in early-stage leukemia trial High school coach charged with sexual contact, transmitting HIV Public Meeting on HIV Patient-Focused Drug Development and HIV Cure Research: June 14, 2013
Information in this article was accurate in December 30, 1998. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.